Bovine spongiform encephalopathy (BSE) and its human equivalent, variant Creutzfeldt±Jakob disease (vCJD), are caused by the same strain of infectious agent, which is similar to, but distinct from, >20 strains of their sheep scrapie homologue. A better understanding of the molecular strain determinants could be obtained from cells in monoculture than from whole animal studies where different cell targeting is commonly a strain-related feature. Although a few cell types can be infected with different strains, the phenotypes of the emergent strains have not been studied. We have cured the scrapie-infected, clonal SMB cell line with pentosan sulfate, stably re-infected it with a different strain of scrapie and shown that biological properties and prion protein pro®les characteristic of each original strain are propagated faithfully in this single non-neuronal cell type. These ®ndings attest to the fact that scrapie strain determinants are stable and host-independent in isolated cells.
Introduction
The prion concept holds that a phenotype can be transmitted across generations using a protein as the carrier of information rather than a nucleic acid (Prusiner, 1982) . It originated in the ®eld of the transmissible spongiform encephalopathies (TSEs) which are progressive neurodegenerative diseases such as scrapie of sheep and goats, Creutzfeldt±Jakob disease (CJD) of humans and bovine spongiform encephalopathy (BSE), and has been extended recently to explain non-Mendelian inheritance of certain traits in yeast and fungi (Masison, 2000) . The existence of several distinct strains of mammalian agent has been recognized for several years and these strains were ®rst de®ned by two principal criteria, their incubation times in Sinc s7 and Sinc p7 inbred mice and their heterozygote cross, and the types and patterns of brain lesions they induce at the terminal stage of disease in these mice (Dickinson et al., 1986) . The prion protein (PrP) is encoded at the Sinc (or Prn-i) locus, and one (or both) of two amino acid differences in the mouse protein encoded by the s7 or p7 alleles is the molecular basis of these host differences in survival time (Moore et al., 1998) . Although genetic elements other than the protein-coding element within the Sinc locus can in¯uence the brain pathology following infection with a particular strain (Moore et al., 1998) , distinct features can be seen which are obviously determined by the strain of inoculated agent independently of the host species (Fraser, 1976; Bruce, 1993) .
The conversion of normal PrP (PrP C ) to a proteaseresistant isoform, PrP Sc , is a key event in the pathogenesis of scrapie and all other prion diseases, and PrP Sc , according to prion theory, is the sole component of the infectious particle (Prusiner, 1998 ) so molecular differences in PrP Sc must form the basis of the different phenotypes of CJD and scrapie. It has been speculated that variation in protease-resistant fragment size or conformation and the degree of its asparagine-linked glycosylation (Bessen and Marsh, 1994; Collinge et al., 1996; Telling et al., 1996; Caughey et al., 1998; Parchi et al., 1998) form the basis of agent strain differences. Such physicochemical differences could`translate' into differences in the survival times and pathology seen with various strains as a consequence of differing rates of production, accumulation and clearance of the prion protein by different cell types within the brain (Safar et al., 1998) . It follows that cell-speci®c variation in conformation and/or degree of glycosylation of PrP would be the effectors of this strain propagation (Weissmann, 1991) . Separating cause of infection from its pathological by-products has been hindered by the need to study strain effects in the whole organism: for example, it has been impossible to determine if a single PrP Sc glycoformÐone molecular signature of a particular strain (Aguzzi and Weissmann, 1997) Ðcan target only one speci®c subset of nerve cells in the brain capable of producing only that glycoform (DeArmond et al., , 1999 . To investigate these processes requires the stable infection of a single cell type with more than one strain of scrapie.
The best de®ned scrapie strains have been isolated and passaged in mice (Dickinson et al., 1986) ; therefore, to avoid interpretational dif®culties arising from interspecies transmission, a mouse cell line would be optimal. However, persistent scrapie infection can be established in only a very few cell lines in vitro. Scrapie-infected mouse C1300 neuroblastoma-derived cell lines ScMNB (Race et al., 1987) or ScN2a (Butler et al., 1988) have been valuable in de®ning events in PrP Sc production (Race et al., 1988; Taraboulos et al., 1990 Taraboulos et al., , 1992 Caughey et al., 1991; McKinley et al., 1991; Vey et al., 1996; Naslavsky et al., 1997) but the wild-type cells have only a low susceptibility to in vitro challenge with scrapie. The cell line we chose for these experiments was SMB (Clarke and Haig, 1970) which was established originally by culture from a brain taken from a mouse clinically affected by the Chandler scrapie isolate and shown to be a cell line of mesodermal origin (Haig and Clarke, 1971) . We reasoned that since SMB cells possessed a high degree of competence in propagating the original infection, a non-infected SMB variant might exhibit equal competence at hosting a newly introduced, different scrapie strain.
Results
Curing SMB with pentosan sulfate In preliminary experiments, when we examined clonally derived colonies of SMB for PrP Sc , a surrogate marker for infectivity, no PrP Sc -negative colonies were identi®ed. We therefore investigated making an uninfected variant by treating the SMB cell line with pentosan sulfate (PS) to cure it of the infection with Chandler scrapie. PS is one of several polyanionic compounds capable of altering the scrapie incubation period in vivo (Diringer and Ehlers, 1991) and has been shown to curtail PrP Sc production and replication of infectivity in ScMNB cells (Caughey and Raymond, 1993; Priola and Caughey, 1994) . When grown for a single passage in the presence of PS at a range of concentrations up to 1 Q 10 ±5 g/ml, the growth of SMB cells was unaffected, but PrP Sc accumulation was inhibited in a dose-dependent manner ( Figure 1A ). The concentration required to inhibit PrP Sc accumulation by 50% (IC 50 ) was 1.5 Q 10 ±7 g/ml. Even at the highest concentrations of PS tested, there was a residual PrP Sc content of~12±14% of the control value, which is in accord with previous work showing that PS effectively inhibits de novo accumulation of PrP Sc but has little effect on reducing the amount of pre-existing PrP Sc in cells (Caughey and Raymond, 1993) .
To effect a permanent cure, SMB cells were grown in the continuous presence of 1 Q 10 ±6 g/ml PS for seven passages so that all pre-formed accumulated PrP Sc was effectively removed through dilution. With an~8-fold increase in cell number at each pass, PrP Sc quickly became undetectable, the seven passages representing a dilution of some 2 Q 10 7 in the initial amount of PrP Sc . PrP Sc subsequently has remained undetectable in this PS-treated cell line, designated SMB-PS, maintained in the absence of PS for >50 passages.
Western blot analysis of total protein extracts of SMB and SMB-PS cells showed a complex pattern of PrP isoforms ( Figure 1B) . In SMB cells, the pattern was typical of a mixture of PrP Sc and PrP C . In SMB-PS cells, a much simpler pattern of PrP isoforms existed composed predominantly of 35±37 kDa isoforms, most probably fulllength diglycosylated PrP C , 30±33 kDa isoforms which were probably a mixture of full-length monoglycosylated and truncated diglycosylated PrP C (Chen et al., 1995) , with very little evidence of non-glycosylated PrP C (26 kDa). Treatment with proteinase K (PK) produced a subset of proteinase-resistant bands from SMB cells typical of PrP Sc , but resulted in the degradation of all the PrP in SMB-PS samples.
To con®rm that the PrP Sc -cured cells had also been cured of infectious Chandler agent, the SMB-PS cell line was tested for scrapie infectivity. Of 18 C57BL mice inoculated intracerebrally with SMB-PS cells, 11 survived to the end of the experiment and were culled without clinical signs at 796 days post-inoculation; the other seven mice were killed as a result of contracting inter-current diseases (on days 370, 377, 473, 604, 628, 673 and 790) . In the entire group of 18 (both inter-current and survivors), there were no symptomatic cases of scrapie, no postmortem histopathological signs of scrapie and no western blot-detectable PrP Sc in any of the brains. The survival curve for SMB-PS-inoculated mice (not shown) is not signi®cantly different from that obtained for sham-inoculated controls but it is signi®cantly longer than for mice inoculated with an equivalent number of SMB cells (see below), and is consistent with SMB-PS being cured of infectivity.
Re-infection of the cured SMB-PS cell Two sources of scrapie have been particularly important in the derivation of individual scrapie strains, the`drowsy goat' source and the Cheviot sheep-passaged SSBP/1 source (Dickinson et al., 1986) . It was the drowsy goat source that ®rst gave clues to the existence of different scrapie strains (Pattison and Millson, 1961; Pattison, 1972) , was the ®rst to be transmitted to mice (Chandler, 1961) and which was also the source of the SMB cell infection. Strains isolated from the drowsy goat source arè Chandler', widely distributed and, after derivation and cloning, known as 139A or RML, and 79A which are all unique to this source (Dickinson et al., 1986) . Among the several strains derived from SSBP/1 is 22F, and its very distinctive biological phenotype makes it ideal for comparison with the original infection of the SMB cell (Dickinson et al., 1986; Bruce, 1993) .
To survey the susceptibility of SMB-PS cells to in vitro infection using the 22F strain, we employed a colony-lift blotting procedure. The SMB cell is phagocytic (Haig and Clarke, 1971 ) and this gross screening method allowed us to introduce very large dilution factors post-challenge, favouring the subsequent detection of PrP Sc synthesized de novo and discriminating it from any residual PrP Sc of the inoculum taken up by the cells. Challenge of SMB-PS cells with 22F-infected brain homogenate resulted in consistently high stimulation of PrP Sc (24.8% of the colonies, n = 4 experiments) while in SMB-PS exposed to normal mouse brain homogenate, PrP Sc remained undetectable (<0.05%, n = 7) ( Figure 2 ). Using 139A or 79A brain homogenates in SMB-PS cell challenges also gave rise to PrP Sc -expressing colonies (11 and 27%, respectively) while controls involving challenge of N2a cells with these three strains gave nothing above background (data not shown). A further control applying the hamster-adapted scrapie (263K) on SMB-PS cells also failed to stimulate PrP Sc -positive colonies. We did not vary the infectious titre used for these challenges, nor was each source titred prior to use. Based on typical clinical mouse brains from these scrapie strains containing 3 Q 10 8 LD 50 units per gram, our challenge would employ~50 LD 50 units per cell. Hamster 263K clinical brain usually has a higher titre containing between 1 Q 10 9 and 1 Q 10 10 LD 50 units per gram.
Given that a substantial proportion of 22F-challenged clones of SMB-PS could be stimulated to express PrP Sc , we proceeded to repeat 22F challenges of SMB-PS cells and, instead of the destructive colony-lift procedure, selected 40 colonies at random and picked them using cloning rings. The expansion of these colonies from 6.4 mm diameter wells to 60 mm diameter dishes was done over six passages and, in those lines where suf®cient cells had grown to permit western blot analysis on a portion of each culture, seven of these remained positive for PrP Sc expression. Importantly, in these seven lines, the synthesis of PrP Sc appeared to be stable through multiple successive passages.
Since SMB cells were originally grown from dispersed cells from whole mouse brain, it was relevant to con®rm that these clones originated from 22F-infected SMB-PS rather than from outgrowth of surviving cells in the 22F scrapie brain homogenate. The founder SMB (and therefore SMB-PS) cells were derived from the Compton White mouse strain while the 22F scrapie brain homogenate was obtained from a VM(Sinc s7 ) congenic mouse. These two mouse strains and their derivative cells have the same PrP genotype but can be distinguished readily by microsatellite genetic analysis. Of the eight microsatellite loci tested, four were informative since they generated PCR products of the same size from DNA isolated from SMB-PS and 22F-challenged SMB-PS cells (Figure 3 ) cells, but of a distinctly different size to that produced on DNA from the VM(Sinc s7 ) congenic mouse. The PrP Sc -positive 22F-challenged SMB-PS lines were therefore derived from SMB-PS cells and did not originate from the mouse donor of the 22F infection.
Comparison of strain characteristics
The biological phenotype (incubation period and lesion pro®le) of the infectious agent in one of the re-infected lines, SMB[22F]F4, was determined at the 14th passage after its infection and compared with that of the infectious agent present in the original parent SMB cell. Clinical signs characteristic of scrapie developed in all the mice inoculated with SMB or SMB[22F]F4 cells, and con®rm-ation of a scrapie infection in every recipient was obtained by standard histological procedures and by western blot analysis of PrP Sc . Consistent with their respective strain properties, the incubation period for mice injected with the SMB cell homogenate (infected with the Chandler strain; 166 T 1.6 days) was shorter than for mice injected with the SMB[22F]F4 cell homogenate (infected with 22F; 384 T 9.5 days) ( Figure 4A ). Although the lengths of these incubation periods cannot be compared directly because the infectious titres were not measured by serial dilution, the incubation periods of SMB[22F]F4-inoculated mice stretch beyond the survival time of animals infected with a limiting dose of the Chandler/SMB agent (250 days maximum; data not shown). To obtain the optimal differentiation of the biological scrapie strain characteristics of the two cell types, brain material from this primary transmission was inoculated into mice of all three Sinc genotypes constituting a secondary transmission experiment.
In the secondary transmission from SMB cells, the rank order of incubation periods ( Figure 4A ) was that expected for the 139A strain. The shortening of the incubation period by 17 days in the C57BL mouse between the primary and secondary transmissions is entirely consistent with a higher infectious dose in brain than in cultured cells. The rank order of incubation periods resulting from the secondary transmission from SMB[22F]F4 cells was entirely characteristic of the 22F scrapie strain and revealed the singularly most informative feature of this scrapie strain; of all the commonly Sinc s7 -passaged strains, 22F is unique in that it effects a shorter incubation period in Sinc p7 than in Sinc s7 recipients (Bruce et al., 1992) . There was a 91 day difference between the incubation periods of the C57BL mouse in the primary and secondary transmissions, too large to be accounted for entirely by dosage but which could be accounted for by the passage history of the 22F source infectious brain that we used. Strain 22F arises when the Sinc p7 -derived scrapie strain 22A is passed in Sinc s7 mice; over the course of three serial passages, the incubation period in C57BL mice shortens from~460 days to~290 days (Bruce et al., 1992) , at which it is stabilized. Our 22F infectious source was 22A that had been passaged once in a Sinc s7 mouse and would therefore give C57BL incubation periods intermediate on this scale. It therefore raises the intriguing possibility that the 22F in SMB[22F]F4 cells has been`frozen' with a phenotype intermediate between early 22F and stable 22F. Irrespective of this incubation period phenomenon, its identi®ca-tion as 22F from the ranking of incubation periods is unassailable.
Our conclusion that the scrapie strains in SMB and SMB[22F]F4 cells were different from each other was reinforced by histopathological analysis of the brains of recipient mice. The patterns of brain pathology of C57BL mice infected with the two cell lines were clearly distinct at both primary and secondary transmission levels. The vacuolation lesion pro®les generated in mice inoculated with SMB cells ( Figure 4B ) were largely characteristic of the Chandler strain and were substantially different from those generated by inoculation with the re-infected SMB[22F]F4 clone which were characteristic of 22F-infected mice ( Figure 4C ). Most striking were the differences in the three white matter areas, which were almost devoid of lesions following inoculation with SMB[22F]F4, whereas the high vacuolation scores in these white matter tracts following SMB infection were entirely characteristic of the Chandler scrapie isolate and its derivative 139A strain in C57BL mice. With both strains, there were minor differences in the severity of vacuolation between primary and secondary transmission, an effect that can be related to initial dose, but in both strains the speci®c trends were constant between ®rst and second pass.
A more recently described scrapie strain-related characteristic is the relative abundance and molecular masses of the three PrP Sc isoforms, the so-called PrP glycoform pro®le. Western blot analyses of PK-treated PrP Sc isolated from the two cell lines indicated that there was a major In both (B) and (C), each point is the mean score at the speci®ed brain region of between 12 and 22 animals, the bars are 1 SEM. Grey matter regions scored: 1, dorsal medulla; 2, cerebellar cortex; 3, superior colliculus; 4, hypothalamus; 5, medial thalamus; 6, hippocampus; 7, septum; 8, thalamic cortex; 9, forebrain cortex. White matter regions scored: 1*, cerebellar white matter; 2*, mesencephalic tegmentum; 3*, pyramidal tract. difference in the relative amounts of the diglycosyl form of PrP Sc from SMB and SMB[22F]F4 cells ( Figure 5A ). SMB cell PrP Sc always contained less diglycosyl PrP than that of SMB[22F]F4 cells, distinct patterns that were entirely stable through many passes; the PrP Sc western blot pro®les used to construct the densitometric data ( Figure 5B Figure 5B , groups 5±8) all had higher D/M ratios. Whereas the PrP Sc glycoform pro®les of the two cell lines were visually distinctive ( Figure 5A , lanes 2 and 6), the differences between the brain samples were not so easily distinguished without densitometry, which together with the natural variations of the brain glycoform samples reinforces earlier ®ndings that scrapie strains with diverse biological phenotypes are not necessarily endowed with very different PrP Sc glycoform pro®les (Somerville et al., 1997) .
A feature common to PrP Sc isolated from both cell lines was that the apparent relative molecular weights of the unglycosylated and diglycosylated PrP isoforms were different from those in all of the brain-derived PrP Sc samples. Cell-derived unglycosylated PrP migrated faster than the brain-derived isoform by some 100±150 Da, while the diglycosyl isoform from the cells was both more disperse and of different mean molecular weight, higher than the respective brain isoform by some 1.5±2.0 kDa. The reason for these disparities is not evident from simple one-dimensional SDS±PAGE analysis but, since such differences have been described in other studies as being due to conformational differences, will bear further investigation.
Discussion SMB cells were isolated as an infected cell line; therefore, there was no uninfected line of comparable cells to use as experimental controls. The persistence of scrapie infectivity in SMB through >150 passages (Clarke, 1979) , with a constant infectious titre, was indicative of a high degree of competence as a host cell for scrapie. To exploit this competence in a study of scrapie strain determinants, we would ®rst need to isolate a revertant, scrapie-free subline of SMB, but our search for subclones spontaneouslỳ cured' of PrP Sc was unsuccessful. PS enabled us to redress this as it proved to be effective at inhibiting PrP Sc accumulation, though when compared with the IC 50 of 1 Q 10 ±9 g/ml obtained with ScMNB cells ) SMB cells were far less sensitive to PS than the neuroblastoma line. There is no clear reason for this difference in sensitivity, but we can speculate that fundamental differences in cell type might be responsible. The mode of action of PS is uncertain although it is known to bind directly to isolated PrP C and recombinant PrP (Brimacombe et al., 1999) and to cause the subcellular re-distribution of PrP C expressed in mouse neuroblastoma cells (Shyng et al., 1995) , so a direct interaction of PS with PrP during the curing process is implicated. Since polyanionic glycosaminoglycans such as PS can bind to numerous cell surface ligands, in particular to components of the extracellular matrix, differences in levels of expression of such ligands between SMB and neuroblastoma cells might serve to sequester PS to a greater extent and thereby modify the amount of polyanion available for binding PrP.
It is probable that the susceptibility of a cell to infection with a TSE agent and its ability to sustain the replication of that infection are governed by separate factors. There are several reports of the ability to infect different types of cell with scrapie in vitro but because SMB had not been raised in this way originally we had to determine its sensitivity to in vitro infection directly. Our ®nding, therefore, that >20% of 22F-challenged SMB-PS cells growing out as clonal colonies had been stimulated to express PrP Sc was encouraging. In contrast, the wild-type N2a neuroblastoma-derived cells had only a low frequency of PrP Sc stimulation, consistent with reports that maximally~1% of cells became infected when challenged with similar Maintenance of scrapie strain phenotype in culture infectious doses by the in vitro challenge route (Butler et al., 1988; Race et al., 1988) . Two recent reports both employing N2a and GT-1 cells, the latter is an immortalized mouse hypothalamic cell line that is sensitive to infection with scrapie (Scha Ètzl et al., 1997) , have concluded that either overexpression of wild-type PrP C (Nishida et al., 2000) or simply pre-selection of cells intrinsically more sensitive to infection (Bosque and Prusiner, 2000) can directly increase the success rate of in vitro infection.
There were two reasons why attaining sustainable infection was one of our aims. The ®rst was simply that any trace of infectivity from the inoculum must be removed by dilution before attempting transmissions to mice. The second was that we wanted a model of infection that is entirely self-sustaining. Cell-free conversion (Kocisko et al., 1994) of PrP C to PrP Sc following their mixing in vitro is well established and it has also been demonstrated that PrP-associated strain-dependent criteria can be transmitted in this way (Bessen et al., 1995) . It is possible, therefore, that the application of exogenous PrP Sc to PrP C -bearing cells might convert PrP C upon contact whether or not this conversion would ultimately become established as a sustained process within the cell. Studying de novo PrP Sc synthesis close to the time of challenge of the cells with exogenous PrP Sc , or at any time prior to the complete removal by dilution of the PrP Sc contained in the challenge material, might therefore be more analogous to studying cell-free conversion and less relevant to the study of the cellular components required for sustainable TSE replication. The successful challenge of SMB-PS cells with infectious scrapie con®rmed our hypothesis that this cell type is a competent scrapie host. Our observation that PrP Sc expression remained constant over >50 passages following infection with 22F without requiring subcloning indicates the inherent stability of this cell system. Our demonstration that highly speci®c strain-related biological phenotypic properties of both the Chandler and 22F strains can be propagated reliably in a single cell type in vitro goes beyond the initial level of study of different scrapie strains in culture, which has been the infection of cells. Rubenstein et al. (1994) showed that the rat PC12 cell line could be infected by different scrapie strains and that resultant alterations in metabolic functions might be strain speci®c. However, scrapie strain properties of the emergent PC12 cultures were not reported. More recently, various scrapie strains have been used to challenge N2a or GT-1 cell-based models, and some degree of PrP Sc glycoform differences has been reported (Nishida et al., 2000) . The fact that our different strain-infected SMB-type cells express scrapie strain-related PrP Sc glycoforms suggests that this will be a useful way to provide early indication of strain-speci®c reproduction prior to the more lengthy but requisite biological strain phenotyping.
The introduction of the 22F strain has been particularly informative in this study. Comparison of scrapie strains by incubation period alone is not ideal, particularly in the primary transmission from the cell where infectious titre is always relatively low. The speci®c ranking of incubation period given by 22F in mice of the three Sinc genotypes is unique in this context. Not only will these cells provide a useful substrate for the study of these scrapie strains in particular and strain-related phenomena in general, but they also signify that other disease-speci®c TSE cultured cell models can be generated.
Materials and methods
Cell culture SMB cells were restored from a stock frozen in 10% (v/v) dimethylsulfoxide (DMSO) at the 74th passage. They were grown in tissue culture plastic dishes in Medium 199 supplemented with 10% newborn bovine serum and 5% fetal bovine serum of Australian origin at 33°C in an atmosphere of 5% CO 2 in air. Medium was changed every 3rd or 4th day, and every 7th±10th day the con¯uent cells were passaged using 0.05% trypsin, 0.002% EDTA, at a split ratio of between 3 and 5. Although suffering a poor cloning ef®ciency, cloning was successful either by limiting dilution or by low density seeding into 90 mm culture plates with selection using cloning rings. One typical clone was selected for all the subsequent work, clone SMB.s15 (referred to throughout as SMB); it exhibited a population doubling time of 33 h at 33°C. A report that scrapie infection of cells in vitro was generally more productive when cultured at a lower temperature led us to use 33°C (Taraboulos et al., 1990) .
Quantitative PrP Sc dot-blot assay Cells growing in 24-well cluster plates were extracted with 0.1 ml of lysis buffer [LyB; 10 mM Tris±HCl pH 7.6, 100 mM NaCl, 10 mM EDTA, 0.5% (v/v) NP-40, 0.5% (w/v) sodium deoxycholate], centrifuged (1000 g, 5 min) and the post-nuclear supernatant applied under gentle vacuum to a nitrocellulose membrane (0.45 mm; BA85; Schleicher and Schuell) via a 96-well dot-blot manifold. The membrane was air-dried thoroughly before application of the in situ processing to discriminate PrP Sc from PrP C (adapted from Taraboulos et al., 1990) . Brie¯y, the membranes were immersed in a 75 mg/ml solution of PK in 20 mM Tris±HCl-buffered saline (TBS) for 60 min at 37°C, stopped with 1 mM phenylmethylsulfonyl¯uoride (PMSF), washed extensively with TBS, then immersed in 3.0 M guanidine thiocyanate in TBS for 10 min at room temperature to denature the residual PrP Sc and expose epitopes. After further extensive washing, the membrane was blocked in 5% fat-free milk powder in phosphate-buffered saline (PBS) then processed with rabbit polyclonal anti-PrP antiserum IB3 or IA8 and developed using ECL (Amersham Pharmacia Biotech). Relative quantitation was made by normalizing loading to cellular protein, measured by detergent-compatible Lowry assay (DC Assay; Bio-Rad) using bovine serum albumin (BSA) as standard, and densitometric analysis of multiple unsaturated ®lms using Phoretix Array 2 software (Non-Linear Dynamics, Newcastle-uponTyne), results being normalized to a ®xed number of untreated SMB cells.
In vitro scrapie infection and colony-lift blotting Cultures of 5 Q 10 4 SMB-PS cells in 0.4 ml of medium seeded in a single well of a 24-well plate and allowed to establish for 24 h were exposed to 0.1 ml of brain homogenate [10% (w/v) in PBS] of normal mouse brain or scrapie-infected brain in the 33°C incubator. After 4 h, this was supplemented with an additional 2 ml of complete medium and incubation continued overnight. They were washed extensively with PBS then grown until con¯uent, at which time they were trypsinized and plated into 10 cm diameter plates at low density and grown on for 4±6 weeks to allow growth of discrete colonies. To obtain a gross numerical analysis of PrP Sc -producing colonies, albeit not a true estimate of the frequency of infection because of their low cloning ef®ciency, these plates were subjected to a colony-lift procedure utilizing PVDF ®lters soaked in LyB, based on that described by Taraboulos et al. (1990) . Except that the ®lters were not air-dried and that we used 100 mg/ml PK to differentiate PrP C from PrP Sc , the blot development procedure was similar to dot-blot processing (above). Colonies in the central 85% of the diameter of the ®lters (so avoiding edge effects) were enumerated with the aid of SigmaScan (v2.5) software (SPSS Inc.). Alternatively, suitably isolated colonies were selected using cloning rings and expanded gradually by continuing culture.
Infectious material and lesion pro®ling
Infectious mouse scrapie brain material was derived by serial passage of scrapie strains of known lineage by 0.02 ml intracerebral injection under halothane anaesthesia of a 10% (w/v) homogenate in saline of brain from a clinically infected mouse. When determined to be in the clinical phase of the disease, brain tissue was dissected out and stored frozen at ±80°C.
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The source of 22F used was a single pass of cloned strain 22A in a VM(Sinc s7 ) mouse which converts 22A irreversibly to 22F.
To challenge mice directly from cultured cells, cultures from two or three dishes at 80±90% con¯uence were washed twice with PBS then scraped into PBS, pooled and put through one rapid freeze±thaw cycle to disrupt them; cells from identical cultures grown in parallel were trypsinized and counted in a haemacytometer chamber to establish numbers. Ethanol (2.3 vols) was added to the freeze±thaw homogenate which was then stored at 4°C for 24 h to (nominally) kill adventitious agents. The precipitate was collected and washed twice with PBS by 10 000 g centrifugation, ®nally being resuspended using cup-horn sonication (Heat Systems) and thorough homogenization in sterile 0.9% (w/v) saline at 2.5 Q 10 6 cell equivalents per ml. Mice under halothane anaesthesia were injected intracerebrally with 30 ml (7.5 Q 10 4 cell equivalents) of this homogenate. Mice continued to be monitored for clinical signs of scrapie; after reaching a pre-de®ned clinical end point, or surviving to~800 days post-inoculation, they were killed and their brains rapidly dissected out. Brains were sectioned coronally and one part ®xed with formaldehyde prior to histological analysis of the pathological lesion pro®le (Fraser, 1976) while the remainder was snap-frozen and stored at ±80°C for later biochemical analysis or for serial subpassage in mice as described above. All animal work was conducted strictly according to local and national guidelines.
Microsatellite analysis
This was done essentially by standard methods (Hearne et al., 1992) . Genomic DNA prepared from cells or from brain tissue using a commercial kit (Qiagen) was used to prime single-stranded length polymorphism (SSLP; microsatellite) PCRs using eight sets of Map-Pair primer pairs (Research Genetics Inc.): D1Mit47, D2Mit92, D2Mit277, D3Mit230, D4Mit26, D7Mit259, D13Mit202 and D17Mit93. We used Tth DNA polymerase (Roche Molecular Biochemicals) in conditions otherwise speci®ed by the primer pair vendor. After 25 cycles of ampli®cation, the DNA products were separated on 2.0 or 2.5% Metaphor agarose (FMC Ltd.) gels in TAE buffer and stained with ethidium bromide. Since these primer pairs were chosen at random, only four pairs gave meaningful data, while the other four gave bands of identical size irrespective of the target DNA.
Ultracentrifugal preparation of PrP Sc for glycoform analysis Cells growing in 60 mm culture plates were rinsed twice with PBS then scraped from the plate in 1.0 ml of LyB and nuclei and cytoskeletal remnants were removed by centrifugation at 2000 g for 5 min. Brain tissue was homogenized at 5% (w/v) in LyB and centrifuged in the same way. The post-nuclear extract of either type of sample was adjusted to 1 mg/ml protein (DC assay; Bio-Rad) and PK added to 25 mg/ml before 37°C, 60 min incubation after which PMSF was added (1 mM) to inhibit PK. The sample was layered over a 0.25 ml of 20% sucrose, 1 mM PMSF cushion in a conical polyallomer ultracentrifuge tube (sample volume was adjusted to ®t by addition of LyB containing 1 mM PMSF) before centrifugation [300 000 g(max), 10°C, 60 min] in a SW50.1 rotor (Beckman). The pellet and~0.1 ml of cushion were resuspended in 2 ml of water by sonication (cup-horn) then centrifuged [541 000 g(max), 10°C, 15 min] in a polycarbonate tube in a TLA-100.3 rotor (Beckman). The PrP Sc -containing pellet was drained thoroughly before solubilization for electrophoresis.
Western blot analysis
Proteins that were obtained by methanol/chloroform precipitation (Wessel and Flugge, 1984) of post-nuclear LyB detergent extracts of cells or by ultracentrifugation were dispersed by sonication (cup-horn) in a modi®ed electrophoresis sample buffer (Laemmli, 1970) containing 4% (w/v) SDS, 5% (v/v) 2-mercaptoethanol, 62.5 mM Tris±HCl pH 6.8, 10% (w/v) sucrose and dissolved by heating at 100°C for 5 min. Proteins were separated on 12.5 or 15% polyacrylamide gels in Tris-glycine-SDS buffer and electrophoretically transferred to PVDF membranes (Immobilon P, Millipore) in 25 mM Tris, 192 mM glycine, 0.05% SDS. Membranes were blocked with 5% fat-free milk powder in PBS (MPBS) for a minimum of 1 h. Polyclonal anti-PrP antiserum IA8 diluted 1:5000 in MPBS was used as primary antibody; blots were developed with ECL reagents (Amersham-Pharmacia Biotech). Non-saturating ®lms were scanned (Epson GT9600 in transmission mode), then calibrated and analysed using Phoretix 1D v4 software (Non-Linear Dynamics Ltd).
